Sign Up to like & get
recommendations!
0
Published in 2021 at "International Journal of Hematology"
DOI: 10.1007/s12185-021-03095-w
Abstract: Emicizumab reduces bleeding in patients with hemophilia A and inhibitors (PwHA-I). Coagulation potential during the perioperative period in emicizumab-treated PwHA-I undergoing surgery remains to be evaluated. We describe a 14-year-old boy with HA-I receiving emicizumab…
read more here.
Keywords:
perioperative hemostatic;
emicizumab prophylaxis;
clot waveform;
receiving emicizumab ... See more keywords